Daniel Alencar Rodrigues

Dr. Daniel Alencar Rodrigues is a Lecturer at the Royal College of Surgeons in Ireland (RCSI) in the School of Pharmacy and Biomolecular Sciences. He holds a PhD in Chemistry from the Federal University of Rio de Janeiro and has held academic positions including Assistant Professor (2017–2018) and Postdoctoral Researcher (2020–2023). His research focuses on medicinal chemistry, organic synthesis, and cancer therapeutics, particularly targeting histone deacetylases (HDACs), phosphatidylinositol-3-kinase (PI3K), and the development of Proteolysis Targeting Chimeras (PROTACs).

• Education:
  • PhD in Chemistry, Federal University of Rio de Janeiro (2015–2019)
  • MSc in Chemistry, Federal University of Rio de Janeiro (2013–2015)
  • Bachelor in Pharmacy, Federal University of Goiás (2008–2012)
  • Postgraduate Diploma in Health Professions Education, RCSI (2023–2024)

His research interests include:

• Design and synthesis of multi-target drugs and PROTACs for cancer therapy
• HDAC6 inhibition in breast and brain cancers
• Computational chemistry for drug design (molecular docking, virtual screening)
• Development of novel anticancer agents targeting metabolic vulnerabilities

Dr. Rodrigues has received the Government of Ireland Postdoctoral Fellowship and has a robust publication record with over 20 peer-reviewed articles. His lab employs a multidisciplinary approach combining organic synthesis, computational modeling, and biological evaluation.

Teaching responsibilities include lecturing in the Master of Pharmacy (MPharm) and BSc in Advanced Therapeutic Technologies programs, with a focus on musculoskeletal and haematological health modules. He emphasizes constructive alignment in teaching practices.